NEJM This Week — October 29, 2020
Featuring articles on osimertinib adjuvant therapy in EGFR-mutated non–small-cell lung cancer, a durable humoral response to SARS-CoV-2, low-dose edoxaban in atrial fibrillation, and exome sequencing for nonimmune hydrops fetalis; a review article on mild or moderate Covid-19; a case report of a man with chronic kidney disease; and Perspective articles on Operation Warp Speed’s strategy and approach, on evaluating and deploying Covid-19 vaccines, on pharmaceutical industry caution vs. federal acceleration of Covid-19 vaccine approval, and on the new stability.
